Aging is the steady loss of function in cells and tissues, and geriatric conditions are what that decline produces: weaker muscle, thinner bone, poorer memory, and incontinence. Mitochondria, the structures that make energy inside every cell, produce less of it with age, and the tissues that depend on that energy weaken. Red light therapy (RLT) delivers red and near-infrared light into those mitochondria and raises the energy they produce.
We reviewed the human studies of red light therapy on 8 age-related conditions and what they reported. Osteoporosis rests on 2 trials, too few to score, and age-related muscle loss returns Mixed Evidence at 31. The brain conditions carry the strongest case: dementia reaches 71, Alzheimer's disease 80, memory loss 75, and mild cognitive impairment 98. Urinary incontinence carries 2 trials of its own. Aging and longevity draw on 2 review papers, and no trial has yet measured red light against human lifespan.
The scores are defined by the CURE Index (Helio Cure's proprietary scoring system). It weighs every human trial on a condition, returns a figure between 0 and 100, and labels the result Effective, Mixed Evidence, or Not Effective. The Index needs 3 human studies to run, so conditions below that threshold appear here as individual trials with no score. Each section gives the wavelengths, doses, and outcomes behind its verdict, drawn from research running 610 to 1400 nanometers (nm), where 810 nm recurs most. The full study list for each scored condition is available on its own page.
Osteoporosis
Osteoporosis is a condition that weakens bones, leaving them fragile, less dense, and prone to breaking. The World Health Organization (WHO) defines the T-score (a measure that compares bone density against that of a healthy young adult) for osteoporosis as minus 2.5 or lower. It develops as the body loses bone mass faster than it builds new bone. Clinicians call osteoporosis a silent disease, since it gives no early warning until a minor fall or bump causes a fracture.
Researchers have tested red light against osteoporosis by 2 routes: high-intensity laser therapy (HILT) at 1064 nm across the lower back and thigh, and low-level laser therapy (LLLT) at 830 nm over single bone sites. The 2 wavelengths contribute different things. Light at 1064 nm reaches up to 5 centimeters (cm) into tissue, deep enough to carry energy through muscle to the bone beneath. Light at 830 nm sits on an absorption peak of cytochrome c oxidase, the enzyme that converts it into cellular energy, so shallower bone takes up more of what arrives. Researchers expect that energy to push bone renewal ahead of breakdown. 2 controlled trials have tested that expectation, 1 on each route.
The randomized controlled trial at Umm Al-Qura University in Mecca in 2017 was the larger of the two. Alayat and colleagues randomized 100 men averaging 54 years, with T-scores of −1.5 or below (low bone density, including the milder stage, osteopenia), into 4 groups. The groups were HILT with exercise, dummy laser with exercise, HILT alone, and dummy laser alone, and the results appeared in the Journal of Physical Therapy Science. HILT was administered at 1064 nm, 3 sessions a week for 12 weeks. Pain on a visual analog scale (VAS) fell from 5.6 to 0.7 in the combined group, compared with 5.2 to 3.6 under placebo. Quality of life improved on the ECOS-16 questionnaire (lower is better) from 47.8 to 22.5, and fall risk dropped from 3.2 to 2.2.
8 patients with complete spinal cord injury made up the 2024 study. Mohammadzadeh and colleagues at the Medical University of Vienna treated 4 bone sites on one side of each patient and published the results in Photobiomodulation, Photomedicine, and Laser Surgery. They left the same 4 sites on the other side alone, so every patient acted as their own comparison. An 830 nm laser at 200 milliwatts (mW) was applied 3 times a week for 8 weeks, with dosing based on bone depth. Bone density rose in the upper thigh bone and the forearm at week 8 and still held at week 15, and vitamin D in the blood rose alongside it. However, the lower thigh bone and the upper shin did not change, and the blood markers that signal new bone formation stayed flat.
Age-Related Muscle Loss
Age-related muscle loss, clinically termed sarcopenia, is the steady decline in muscle size, muscle strength, and physical performance that comes with age. It develops as the body rebuilds muscle more slowly, the nerves supplying each muscle thin out, and daily activity drops away. The loss weakens grip, slows walking, and raises the risk of falls.
We evaluated the research on age-related muscle loss across 6 human studies covering 182 participants, of which 2 were Effective, 1 was Partially Effective, and 3 were Not Effective. That split puts the CURE Index score at 31 out of 100, a verdict of Mixed Evidence within the Limited Confidence band. Included studies ran from 630 to 850 nm and cited 808 nm most often.
Dementia
Dementia is a group of brain conditions that gradually wear down memory, reasoning, and the ability to manage daily tasks. Damage to brain cells, reduced blood flow to the brain, and protein build-up in brain tissue are the common causes. The decline costs independence, disturbs sleep, and unsettles mood.
The CURE Index scores red light therapy for dementia 71 out of 100, which falls within the Strong Confidence band, with a verdict of Effective. That score rests on 4 human studies and 123 participants, and the evidence on dementia splits 3 Effective against 1 Not Effective. Wavelengths spanned 630 to 1080 nm, and 810 nm drew the most citations.
Alzheimer's Disease
Alzheimer's disease (AD) is a progressive brain disease that destroys memory, language, and a sense of direction. It is the most common of several causes of dementia, and factors like age, inherited genes, high blood pressure, or head injury raise the risk. The effects of Alzheimer's worsen over time, moving from mild forgetfulness to severe physical and cognitive decline.
12 human studies covering 265 participants tested red light therapy on Alzheimer's disease, and 9 were Effective, 2 Partially Effective, and 1 Not Effective. That record moves the CURE Index to 80 out of 100, a score at Strong Confidence, and the verdict is Effective. The research on Alzheimer's disease spread across 620 to 1400 nm wavelengths, leaning most on 810 nm.
Memory Loss
Memory loss is difficulty forming new memories, holding on to them, and recalling them later, but not every lapse points to a disease. It is caused by aging, poor sleep, some prescription medicines, and vitamin B12 deficiency. The effects show up as repeated questions, misplaced belongings, and blank patches around recent conversations.
Our review of red light therapy for memory loss identified 10 human studies across 349 participants, of which 6 were Effective and 4 Partially Effective. The CURE Index converts that record into 75 out of 100, a score inside the Strong Confidence band, and it returns an Effective verdict. Testing across the studies on memory loss ran from 620 to 1400 nm, and 1064 nm appeared most often.
Mild Cognitive Impairment (MCI)
Mild cognitive impairment (MCI) is a noticeable decline in memory, but the symptoms are not severe enough to disrupt daily independent living. Medical, lifestyle or brain changes cause it, and it raises the risk of dementia later.
5 human studies of red light therapy for mild cognitive impairment were evaluated, and they all came back Effective, across 178 participants. The CURE Index ranks that result at 98 out of 100, which falls within the Strong Confidence band, and the verdict is Effective. The research covered wavelengths ranging from 610 through 1400 nm, where 810 nm was most cited.
Urinary Incontinence
Urinary incontinence is the involuntary loss of urine, defined by the International Continence Society (ICS) in 2 main forms: a stress form triggered by coughing, sneezing, and exertion, and an urgency form driven by an overactive bladder (OAB). It is caused by weakened pelvic floor muscles, childbirth, prostate surgery, and aging. The leaks that follow cost sleep, confidence, and social life. Pelvic floor muscle training is the first-line treatment, but the muscles fatigue during the exercises.
Researchers have tested 2 routes against that fatigue: an 808 nm laser held against the pelvic floor during strengthening work, and a 650 nm laser placed on the CV4 and CV6 acupuncture points on the lower abdomen. They propose that light absorbed at either site raises nitric oxide (NO), a molecule that widens blood vessels, relaxes the bladder's muscle, and boosts energy in the cells it reaches. Researchers expect that relaxation to settle the bladder, and that energy to keep a tiring pelvic floor at work. 2 randomized controlled trials have tested those routes, 1 on each, both in women.
In 2023, da Silva and colleagues at the University of Vale do Paraíba in Brazil ran a randomized, double-blinded, placebo-controlled trial on 22 women with stress urinary incontinence and published it in Lasers in Medical Science. Both groups trained with vaginal cones. One group received an 808 nm laser at 100 mW, delivering 3 joules (J) at each of 6 vaginal points, and the other took a placebo laser. Quality of life scores improved from 11.63 to 7.81, and pelvic floor strength rose from 8.36 to 13.81, each at p < 0.05, with endurance reaching 5 against 3.90 under placebo. The authors called it significant efficacy against pelvic floor muscle fatigue. However, 22 volunteers is a small sample, and the trial tracked muscle performance rather than the leaks.
The second trial counted those leaks directly. Ahmed and colleagues at Al Azhar University in Cairo published a randomized controlled trial in 2025 on 50 women with bladder overactivity confirmed by bladder-pressure testing. Each received 8 sessions of 650 nm laser at 5 milliwatts (mW) or less, twice weekly for 4 weeks, 10 minutes on each of the same 2 points. Daily toilet trips fell to 7 against 12 in controls, night-time trips to 0.8 against 4, urgency scores to 0 or 1 against 1 to 5, and urge leaks to none against 1 to 3. However, the trial ran at a single center without a dummy laser, and the authors called for larger studies.
Aging & Longevity
Aging is the progressive loss of function in cells and tissues, and longevity is the length of healthy life it shortens. Mitochondria produce less energy, cells divide less often, and the immune system weakens, which raises the risk of disease. The clearest example is the thymus, the gland that trains the body's infection-fighting T-cells, which shrinks steadily from adolescence onward, and researchers call that shrinkage programmed aging.
Researchers have proposed red light therapy as a way to act on that shrinkage, and on the wider decline behind it. Red and near-infrared light between 600 and 1200 nm reaches the mitochondria, where cells make their energy, and absorption there raises energy output while lowering oxidative stress. Researchers expect that extra energy to regenerate the shrinking thymus, keep transplanted cells alive through their first days, and slow the damage behind age-related disease. 2 review papers have surveyed the evidence. However, no clinical trial has yet tested red light therapy against human lifespan or any measure of biological age.
The narrower case came from the Chinese University of Hong Kong. Odinokov and Hamblin published it as a perspective article in the Journal of Biophotonics in 2018. They set out 2 ways light acts on the thymus. It prompts the body to make melatonin outside the pineal gland, and it stimulates bone marrow stem cells that rebuild the gland. The wavelengths they cite run 600 to 700 nm, 760 to 1200 nm, and 980 nm, at 1 to 500 milliwatts per square centimeter (mW/cm²). However, a perspective article argues a case rather than testing one. It reports no participants, no protocol, and no results, and the authors present thymus regrowth and a longer life as something still to be tested.
A broader case followed 7 years later. Mehran and colleagues published a review in the European Journal of Translational Myology in 2025. The laser therapy they describe runs at 620 to 1400 nm and reaches the body 4 ways: through the skin, into blood vessels, into joints, and into the fluid-filled tissue between organs. They pair it with cell therapies and nutritional medicine, arguing that transplanted cells need working mitochondria to survive their first days. However, the review reports no participants, no methods, and no results, and it ends by asking for the idea to be tested.
How does Red Light Therapy Work for the Elderly?
Red light therapy in the elderly targets the energy mitochondria lose with age. Cytochrome c oxidase, an enzyme inside the mitochondria, absorbs red and near-infrared light from 610 to 1400 nm and raises adenosine triphosphate (ATP), the cell's energy supply. That absorption frees nitric oxide, widens blood vessels, improves oxygen delivery, and lowers oxidative stress. The brain responds most strongly to these changes, and older adults regain memory and reasoning. However, aging muscle responds least. Seniors apply the light at home with a panel over the target area, 10 to 20 minutes a session, 5 days a week. Trials in older adults report no clinically significant side effects.
How to Use Red Light Therapy for Seniors at Home?
To use red light therapy at home, seniors can sit, stand, or lie in a comfortable position and expose the target area to a red and near-infrared light therapy panel. The skin should be bare, since clothing blocks the light. Treat the forehead for memory and cognition, the lower back and thigh for bone, and the lower abdomen for bladder control. Chao published a home-based trial in Photobiomodulation, Photomedicine, and Laser Surgery in 2019 and trained each patient's spouse or child to position the device. Position determines the dose that lands, so ask a second person to place the panel.
How Often should Seniors Use Red Light Therapy?
Seniors should use red light therapy 5 days a week, 10 to 20 minutes a session. Keep the sessions going. Saltmarche and colleagues reported in Photomedicine and Laser Surgery in 2017 that cognitive scores slid back during the 4 weeks after treatment stopped, and one family saw decline within a week. Benefits are held while the sessions continue, so treat maintenance as part of the schedule rather than an optional extra.
Is Red Light Therapy Safe for Seniors?
Yes. The studies on this page reported few side effects. Red light therapy carries no ultraviolet (UV) radiation, little heat at treatment doses, and no incision. Mild warmth at the treated site and temporary effects on eyesight appeared in some cases. Both passed without treatment, and eyewear is worn to limit the eye effects. Medication is the main caution. Korzeniowska and colleagues reported in Therapeutics and Clinical Risk Management in 2019 that potentially photosensitizing drugs make up 22.4% of what older people take. A few react to visible light, and the skin can redden or blister. So, it is advisable to consult a clinician before beginning sessions.
Do Helio Cure Panels Use the Wavelengths Studied for Age-Related Conditions?
Yes. Helio Cure panels run 810, 830, and 1064 nm, the wavelengths used in the cognitive and osteoporosis studies, alongside 630, 660, and 850 nm. The dementia, Alzheimer's disease, and mild cognitive impairment research cites 810 nm most often. The memory loss studies cite 1064 nm, and the osteoporosis trials used 1064 and 830 nm.
References
- https://pmc.ncbi.nlm.nih.gov/articles/pmid/40341289/
- https://linkinghub.elsevier.com/retrieve/pii/S1568-1637(17)30005-3
- https://pmc.ncbi.nlm.nih.gov/articles/pmid/29227581/
- https://pmc.ncbi.nlm.nih.gov/articles/pmid/28932011/
- https://journals.sagepub.com/doi/10.1089/photob.2023.0195
- https://dx.doi.org/10.1007/s10103-023-03919-7
- https://pmc.ncbi.nlm.nih.gov/articles/pmid/39912973/
- https://journals.sagepub.com/doi/abs/10.1089/photob.2018.4555
- https://journals.sagepub.com/doi/10.1089/pho.2016.4227